Melanoma: Cutaneous, Version 2.2024 Featured Updates to the NCCN Guidelines

Susan M. Swetter; Douglas Johnson; Mark R. Albertini; Christopher A. Barker; Sarah Bateni; Joel Baumgartner; Shailender Bhatia; Christopher Bichakjian; Genevieve Boland; Sunandana Chandra; Bartosz Chmielowski; Dominick DiMaio; Roxana Dronca; Ryan C. Fields; Martin D. Fleming; Anjela Galan; Samantha Guild; John Hyngstrom; Giorgos Karakousis; Kari Kendra; Maija Kiuru; Julie R. Lange; Ryan Lanning; Theodore Logan; Daniel Olson; Anthony J. Olszanski; Patrick A. Ott; Merrick I. Ross; Luke Rothermel; April K. Salama; Rohit Sharma; Joseph Skitzki; Emily Smith; Katy Tsai; Evan Wuthrick; Yan Xing; Nicole McMillian; Sara Espinosa

doi:10.6004/jnccn.2024.0036

Melanoma: Cutaneous, Version 2.2024 Featured Updates to the NCCN Guidelines

Susan M. Swetter, Douglas Johnson, Mark R. Albertini, Christopher A. Barker, Sarah Bateni, Joel Baumgartner, Shailender Bhatia, Christopher Bichakjian, Genevieve Boland, Sunandana Chandra, Bartosz Chmielowski, Dominick DiMaio, Roxana Dronca, Ryan C. Fields, Martin D. Fleming, Anjela Galan, Samantha Guild, John Hyngstrom, Giorgos Karakousis, Kari KendraMaija Kiuru, Julie R. Lange, Ryan Lanning, Theodore Logan, Daniel Olson, Anthony J. Olszanski, Patrick A. Ott, Merrick I. Ross, Luke Rothermel, April K. Salama, Rohit Sharma, Joseph Skitzki, Emily Smith, Katy Tsai, Evan Wuthrick, Yan Xing, Nicole McMillian, Sara Espinosa

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

The NCCN Guidelines for Cutaneous Melanoma (termed Melanoma: Cutaneous) provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients. These NCCN Guidelines Insights focus on the update to neoadjuvant systemic therapy options and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Cutaneous Melanoma.

Original language	English (US)
Pages (from-to)	290-298
Number of pages	9
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	22
Issue number	5
DOIs	https://doi.org/10.6004/jnccn.2024.0036
State	Published - Jul 1 2024

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2024.0036

Cite this

Swetter, S. M., Johnson, D., Albertini, M. R., Barker, C. A., Bateni, S., Baumgartner, J., Bhatia, S., Bichakjian, C., Boland, G., Chandra, S., Chmielowski, B., DiMaio, D., Dronca, R., Fields, R. C., Fleming, M. D., Galan, A., Guild, S., Hyngstrom, J., Karakousis, G., ... Espinosa, S. (2024). Melanoma: Cutaneous, Version 2.2024 Featured Updates to the NCCN Guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 22(5), 290-298. https://doi.org/10.6004/jnccn.2024.0036

Swetter, SM, Johnson, D, Albertini, MR, Barker, CA, Bateni, S, Baumgartner, J, Bhatia, S, Bichakjian, C, Boland, G, Chandra, S, Chmielowski, B, DiMaio, D, Dronca, R, Fields, RC, Fleming, MD, Galan, A, Guild, S, Hyngstrom, J, Karakousis, G, Kendra, K, Kiuru, M, Lange, JR, Lanning, R, Logan, T, Olson, D, Olszanski, AJ, Ott, PA, Ross, MI, Rothermel, L, Salama, AK, Sharma, R, Skitzki, J, Smith, E, Tsai, K, Wuthrick, E, Xing, Y, McMillian, N & Espinosa, S 2024, 'Melanoma: Cutaneous, Version 2.2024 Featured Updates to the NCCN Guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 22, no. 5, pp. 290-298. https://doi.org/10.6004/jnccn.2024.0036

@article{898b741a7f654962ba1287d42916738f,

title = "Melanoma: Cutaneous, Version 2.2024 Featured Updates to the NCCN Guidelines",

abstract = "The NCCN Guidelines for Cutaneous Melanoma (termed Melanoma: Cutaneous) provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients. These NCCN Guidelines Insights focus on the update to neoadjuvant systemic therapy options and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Cutaneous Melanoma.",

author = "Swetter, {Susan M.} and Douglas Johnson and Albertini, {Mark R.} and Barker, {Christopher A.} and Sarah Bateni and Joel Baumgartner and Shailender Bhatia and Christopher Bichakjian and Genevieve Boland and Sunandana Chandra and Bartosz Chmielowski and Dominick DiMaio and Roxana Dronca and Fields, {Ryan C.} and Fleming, {Martin D.} and Anjela Galan and Samantha Guild and John Hyngstrom and Giorgos Karakousis and Kari Kendra and Maija Kiuru and Lange, {Julie R.} and Ryan Lanning and Theodore Logan and Daniel Olson and Olszanski, {Anthony J.} and Ott, {Patrick A.} and Ross, {Merrick I.} and Luke Rothermel and Salama, {April K.} and Rohit Sharma and Joseph Skitzki and Emily Smith and Katy Tsai and Evan Wuthrick and Yan Xing and Nicole McMillian and Sara Espinosa",

note = "Publisher Copyright: {\textcopyright} JNCCN—Journal of the National Comprehensive Cancer Network.",

year = "2024",

month = jul,

day = "1",

doi = "10.6004/jnccn.2024.0036",

language = "English (US)",

volume = "22",

pages = "290--298",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "5",

}

TY - JOUR

T1 - Melanoma

T2 - Cutaneous, Version 2.2024 Featured Updates to the NCCN Guidelines

AU - Swetter, Susan M.

AU - Johnson, Douglas

AU - Albertini, Mark R.

AU - Barker, Christopher A.

AU - Bateni, Sarah

AU - Baumgartner, Joel

AU - Bhatia, Shailender

AU - Bichakjian, Christopher

AU - Boland, Genevieve

AU - Chandra, Sunandana

AU - Chmielowski, Bartosz

AU - DiMaio, Dominick

AU - Dronca, Roxana

AU - Fields, Ryan C.

AU - Fleming, Martin D.

AU - Galan, Anjela

AU - Guild, Samantha

AU - Hyngstrom, John

AU - Karakousis, Giorgos

AU - Kendra, Kari

AU - Kiuru, Maija

AU - Lange, Julie R.

AU - Lanning, Ryan

AU - Logan, Theodore

AU - Olson, Daniel

AU - Olszanski, Anthony J.

AU - Ott, Patrick A.

AU - Ross, Merrick I.

AU - Rothermel, Luke

AU - Salama, April K.

AU - Sharma, Rohit

AU - Skitzki, Joseph

AU - Smith, Emily

AU - Tsai, Katy

AU - Wuthrick, Evan

AU - Xing, Yan

AU - McMillian, Nicole

AU - Espinosa, Sara

PY - 2024/7/1

Y1 - 2024/7/1

N2 - The NCCN Guidelines for Cutaneous Melanoma (termed Melanoma: Cutaneous) provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients. These NCCN Guidelines Insights focus on the update to neoadjuvant systemic therapy options and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Cutaneous Melanoma.

AB - The NCCN Guidelines for Cutaneous Melanoma (termed Melanoma: Cutaneous) provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients. These NCCN Guidelines Insights focus on the update to neoadjuvant systemic therapy options and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Cutaneous Melanoma.

UR - http://www.scopus.com/inward/record.url?scp=85199127199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85199127199&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2024.0036

DO - 10.6004/jnccn.2024.0036

M3 - Article

C2 - 39019054

AN - SCOPUS:85199127199

SN - 1540-1405

VL - 22

SP - 290

EP - 298

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 5

ER -

Melanoma: Cutaneous, Version 2.2024 Featured Updates to the NCCN Guidelines

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this